Southeast Asia needs a revolving fund for vaccines

Ahmad, Fariza Nasreen Seraj; Khor, Swee Kheng; Lim, Jeremy; Roth, Susann; Dewi, Shita; Becerra, F. E.

doi:10.1016/s2214-109x(22)00406-5

Cited by 3 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…-enhance disease surveillance for early outbreak detection; -establish and harmonise research tools such as virus, serum or cell line banks that will enable the rapid assessment of transmission dynamics and population susceptibility to emerging pathogens in the future; -accelerate local medical diagnostics and equipment development with pilot production, quality assurance, regulatory clearance and scale-ups; -adopt One Health and Planetary Health approaches to address human threats related to animals, climate, and the environment; -establish formal and informal scientific networks for information and knowledge sharing to enable rapid response to outbreaks before they escalate into pandemics; -collaborative funding to support efforts in pandemic preparedness, for example, a revolving fund for vaccine development and procurement for the ASEAN region could be established by fostering public and private collaborations [10].…”

Section: The Association Of Southeast Asian Nations (Asean) Sero-surv...mentioning

confidence: 99%

Charting the path forward in Southeast Asia: Learning from the COVID-19 vaccination challenges in six ASEAN countries

Fu,

Pukhari,

Dela Cruz

et al. 2024

J Glob Health

View full text Add to dashboard Cite

W ith a population exceeding 630 million (8% of the global population), the ten member states of the Association of Southeast Asian Nations (ASEAN) accounted for approximately 61 million (7.9%) of global COVID-19 cases and 808 166 (11.6%) of deaths, with case fatality rate (CFR) of 1.3% by the end of 2023 [1]. The actual figures are certain to be at least several-fold higher, with estimates suggesting an excess mortality of 1.2 million in the first two years of the pandemic. Despite the World Health Organization's (WHO) 4 May 2023 declaration that coronavirus disease 2019 (COVID-19) is no longer a public health emergency, it remains a global threat. The global response to the COVID-19 pandemic has highlighted the importance of collaborative networks within ASEAN, particularly in scientific information, technology and research exchange, resource mobilisation, and capacity building. While individual ASEAN country implemented responses with varying degrees of success, a unified and cohesive regional approach is crucial for

show abstract

Section: The Association Of Southeast Asian Nations (Asean) Sero-surv...mentioning

confidence: 99%

Charting the path forward in Southeast Asia: Learning from the COVID-19 vaccination challenges in six ASEAN countries

Fu,

Pukhari,

Dela Cruz

et al. 2024

J Glob Health

View full text Add to dashboard Cite

show abstract

“…Por lo anterior, el personal de la OPS y los asociados externos reconocen al Fondo Rotatorio como una contribución destacada de la OPS a la respuesta frente a la COVID-19 (126). Una publicación científica reciente apunta al Fondo Rotatorio de la OPS como un modelo para otras regiones del mundo (138).…”

Section: Valor Añadidounclassified

Evaluación de la respuesta de la Organización Panamericana de la Salud a la COVID-19 2020-2022. Volumen I. Informe final

2023

View full text Add to dashboard Cite

En el presente informe se presentan las conclusiones sobre la evaluación de la respuesta de la Organización Panamericana de la Salud (OPS) a la pandemia de COVID‑19 en la Región de las Américas en el período comprendido entre enero del 2020 y agosto del 2022. En el informe se presenta información sobre el apoyo de la OPS a los Estados Miembros de conformidad con el plan estratégico de preparación y respuesta frente a la COVID‑19 de la Organización Mundial de la Salud. Los datos recopilados durante la evaluación se consolidaron y analizaron a nivel estratégico, organizacional y operativo. Se centra en la OPS como organización y, si bien no se evalúan las respuestas de los Estados Miembros a la pandemia, se presenta información sobre la manera en que la OPS colaboró con los Estados Miembros y les brindó apoyo durante la respuesta. Además de brindar información relacionada con la pandemia de COVID‑19 en la Región de las Américas y la respuesta programática de la OPS, en el informe se presenta información sobre los logros clave, así como sobre los factores facilitadores y limitantes, las brechas y las enseñanzas que han surgido de la respuesta de la OPS a la pandemia de COVID‑19, que sirven para documentar la preparación y la respuesta a futuras emergencias de salud pública. Finalmente, se presentan recomendaciones basadas en la evidencia sobre medidas correctivas que fortalezcan la respuesta a futuras pandemias, a la vez que se forja una recuperación resiliente en la Región. Estas recomendaciones se centran en la gobernanza y gestión de la OPS, los mecanismos regionales especializados, la diversificación de los modelos de financiamiento y el uso de nuevas tecnologías.

show abstract

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Bibera,

San Martin,

van Oorschot

et al. 2024

Vaccines

View full text Add to dashboard Cite

The burden of herpes zoster (HZ) is recognized worldwide; however, there is seemingly limited information on incidence and vaccination practices in Southeast Asia (SEA). A scientific workshop was held by the Zoster Experts’ Network to exchange and consolidate insights on the burden of HZ and the patient pathway in SEA. The workshop included practicing clinical experts and public health specialists/epidemiologists from Indonesia, Malaysia, the Philippines, Thailand, and Vietnam. It aimed to identify gaps in the literature, outline patient pathways, and evaluate HZ vaccine recommendations among these countries. Consensus was identified on the substantial lack of epidemiological data on HZ in SEA and the need to investigate the impact of age, immunocompromising conditions, and comorbidities on the incidence and severity of HZ in the region. However, available data in SEA did indicate a rising disease and socioeconomic burden of HZ, with concerns that current treatment strategies for HZ are suboptimal. The HZ patient pathways generated by the experts highlighted common themes and differences between the five countries. Furthermore, the experts highlighted the lack of awareness of HZ and its impact on patients’ quality of life, among patients and healthcare professionals. Evaluation of the current local HZ vaccine recommendations further showed differences in age and the inclusion of at-risk populations between countries. The workshop outcomes emphasize the need for further HZ surveillance in SEA. Efforts to align and address leakage within the patient pathway and raise awareness on the impact of HZ should be prioritized. Awareness initiatives and alignment on vaccine recommendations are also needed.

show abstract

Southeast Asia needs a revolving fund for vaccines

Cited by 3 publications

References 3 publications

Charting the path forward in Southeast Asia: Learning from the COVID-19 vaccination challenges in six ASEAN countries

Charting the path forward in Southeast Asia: Learning from the COVID-19 vaccination challenges in six ASEAN countries

Evaluación de la respuesta de la Organización Panamericana de la Salud a la COVID-19 2020-2022. Volumen I. Informe final

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Contact Info

Product

Resources

About